These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20447106)

  • 1. Pseudohypopyon following intravitreal triamcinolone acetonide injection in a phakic eye.
    Simon S; Gray T; Dhanapala M; Gilhotra J
    Clin Exp Ophthalmol; 2010 Jan; 38(1):76-7. PubMed ID: 20447106
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
    Moshfeghi AA; Scott IU; Flynn HW; Puliafito CA
    Am J Ophthalmol; 2004 Sep; 138(3):489-92. PubMed ID: 15364241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide--case reports.
    Campos VE; Maia A; Muccioli C; Belfort R
    Arq Bras Oftalmol; 2005; 68(2):251-2. PubMed ID: 15905950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular morbidity associated with intravitreal triamcinolone acetonide.
    Konstantopoulos A; Williams CP; Newsom RS; Luff AJ
    Eye (Lond); 2007 Mar; 21(3):317-20. PubMed ID: 16710433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB; Kreissig I; Degenring RF
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide treatment for serpiginous choroiditis.
    Adigüzel U; Sari A; Ozmen C; Oz O
    Ocul Immunol Inflamm; 2006 Dec; 14(6):375-8. PubMed ID: 17162609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
    Rahimi M; Shahrzad SS; Banifatemi M
    Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].
    Jonas JB; Degenring R
    Klin Monbl Augenheilkd; 2002 Jun; 219(6):429-32. PubMed ID: 12136438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular syphilis unmasked following intravitreal triamcinolone injection.
    Mushtaq B; Gupta R; Elsherbiny S; Murray PI
    Ocul Immunol Inflamm; 2009; 17(3):213-5. PubMed ID: 19585366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Macular oedema and intravitreal triamcinolone injections].
    Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
    Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid therapy of oedematous and neovascular eye diseases].
    Lang GE
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):383. PubMed ID: 12830390
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema.
    Chan CK; Mohamed S; Shanmugam MP; Tsang CW; Lai TY; Lam DS
    Br J Ophthalmol; 2006 Sep; 90(9):1137-41. PubMed ID: 16707525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cataract surgery after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring RF
    Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.
    Jonas JB; Kreissig I; Degenring RF; Kamppeter BA
    Br J Ophthalmol; 2005 Jan; 89(1):122. PubMed ID: 15615762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
    Saraiva VS; Sallum JM; Farah ME
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.